- Home
- ICLK vs PTN Comparison
ICLK vs PTN Comparison
Compare ICLK & PTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLK
- PTN
- Stock Information
- Founded
- ICLK 2009
- PTN 1986
- Country
- ICLK Hong Kong
- PTN United States
- Employees
- ICLK N/A
- PTN N/A
- Industry
- ICLK Computer Software: Prepackaged Software
- PTN Biotechnology: Pharmaceutical Preparations
- Sector
- ICLK Technology
- PTN Health Care
- Exchange
- ICLK Nasdaq
- PTN Nasdaq
- Market Cap
- ICLK 29.1M
- PTN 25.4M
- IPO Year
- ICLK 2017
- PTN 1993
- Fundamental
- Price
- ICLK $3.13
- PTN $1.07
- Analyst Decision
- ICLK
- PTN Strong Buy
- Analyst Count
- ICLK 0
- PTN 1
- Target Price
- ICLK N/A
- PTN $17.00
- AVG Volume (30 Days)
- ICLK 24.9K
- PTN 253.3K
- Earning Date
- ICLK 12-11-2024
- PTN 11-14-2024
- Dividend Yield
- ICLK N/A
- PTN N/A
- EPS Growth
- ICLK N/A
- PTN N/A
- EPS
- ICLK N/A
- PTN N/A
- Revenue
- ICLK $133,217,000.00
- PTN $4,490,090.00
- Revenue This Year
- ICLK $26.49
- PTN N/A
- Revenue Next Year
- ICLK $12.11
- PTN N/A
- P/E Ratio
- ICLK N/A
- PTN N/A
- Revenue Growth
- ICLK N/A
- PTN N/A
- 52 Week Low
- ICLK $1.03
- PTN $0.68
- 52 Week High
- ICLK $4.01
- PTN $5.65
- Technical
- Relative Strength Index (RSI)
- ICLK 47.28
- PTN 45.02
- Support Level
- ICLK $3.05
- PTN $1.06
- Resistance Level
- ICLK $3.20
- PTN $1.26
- Average True Range (ATR)
- ICLK 0.13
- PTN 0.14
- MACD
- ICLK -0.02
- PTN -0.00
- Stochastic Oscillator
- ICLK 29.27
- PTN 9.46
About ICLK iClick Interactive Asia Group Limited
iClick Interactive Asia Group Ltd is an enterprise and marketing cloud Platform in China. It offers a consumer full lifecycle solution that addresses client's needs from traffic acquisition, customer relations management, and business decision optimization driven by data analytics in the retail era. It has two operating segments: Marketing Solutions, and Enterprise Solutions. Geographically, it derives the majority revenue from Mainland China and also has a presence in Hong Kong and other countries.
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.